GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (LTS:0RPD) » Definitions » Change In Receivables

Vifor Pharma AG (LTS:0RPD) Change In Receivables : CHF34 Mil (TTM As of Dec. 2021)


View and export this data going back to 2014. Start your Free Trial

What is Vifor Pharma AG Change In Receivables?

Vifor Pharma AG's change in receivables for the quarter that ended in Dec. 2021 was CHF51 Mil. It means Vifor Pharma AG's Accounts Receivable declined by CHF51 Mil from Jun. 2021 to Dec. 2021 .

Vifor Pharma AG's change in receivables for the fiscal year that ended in Dec. 2021 was CHF34 Mil. It means Vifor Pharma AG's Accounts Receivable declined by CHF34 Mil from Dec. 2020 to Dec. 2021 .

Vifor Pharma AG's Accounts Receivable for the quarter that ended in Dec. 2021 was CHF374 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Vifor Pharma AG's Days Sales Outstanding for the six months ended in Dec. 2021 was 70.75.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Vifor Pharma AG's liquidation value for the six months ended in Dec. 2021 was CHF317 Mil.


Vifor Pharma AG Change In Receivables Historical Data

The historical data trend for Vifor Pharma AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vifor Pharma AG Change In Receivables Chart

Vifor Pharma AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -68.90 -113.10 40.10 -84.90 33.90

Vifor Pharma AG Semi-Annual Data
Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.40 -23.30 -61.60 -16.70 50.60

Vifor Pharma AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vifor Pharma AG  (LTS:0RPD) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Vifor Pharma AG's Days Sales Outstanding for the quarter that ended in Dec. 2021 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=374.2/965.3*91
=70.75

2. In Ben Graham's calculation of liquidation value, Vifor Pharma AG's accounts receivable are only considered to be worth 75% of book value:

Vifor Pharma AG's liquidation value for the quarter that ended in Dec. 2021 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=993.6-1130.5+0.75 * 374.2+0.5 * 347
=317

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vifor Pharma AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of Vifor Pharma AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Vifor Pharma AG (LTS:0RPD) Business Description

Traded in Other Exchanges
N/A
Address
Rechenstrasse 37, Saint Gallen, CHE, 9014
Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Vifor Pharma AG (LTS:0RPD) Headlines

No Headlines